Results obtained from xenograft mouse models of pancreatic cancer confirmed the relevance of BCL9L for tumor growth in vivo and showed a highly significant reduction in the number of liver metastases upon BCL9L knockdown. This evidence concerns the gene BCL9L and pancreatic neoplasm.